Annual gross profit:
$12.23B+$930.10M(+8.23%)Summary
- As of today (April 25, 2025), REGN annual gross profit is $12.23 billion, with the most recent change of +$930.10 million (+8.23%) on December 31, 2024.
- During the last 3 years, REGN annual gross profit has fallen by -$1.40 billion (-10.29%).
- REGN annual gross profit is now -10.29% below its all-time high of $13.63 billion, reached on December 31, 2021.
Performance
REGN Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$3.22B-$5.80M(-0.18%)Summary
- As of today (April 25, 2025), REGN quarterly gross profit is $3.22 billion, with the most recent change of -$5.80 million (-0.18%) on December 31, 2024.
- Over the past year, REGN quarterly gross profit has increased by +$306.50 million (+10.51%).
- REGN quarterly gross profit is now -27.47% below its all-time high of $4.44 billion, reached on June 30, 2021.
Performance
REGN quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$12.23B+$306.50M(+2.57%)Summary
- As of today (April 25, 2025), REGN TTM gross profit is $12.23 billion, with the most recent change of +$306.50 million (+2.57%) on December 31, 2024.
- Over the past year, REGN TTM gross profit has increased by +$930.10 million (+8.23%).
- REGN TTM gross profit is now -12.47% below its all-time high of $13.97 billion, reached on March 31, 2022.
Performance
REGN TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
REGN Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.2% | +10.5% | +8.2% |
| 3 y3 years | -10.3% | +10.5% | +8.2% |
| 5 y5 years | +111.2% | +10.5% | +8.2% |
REGN Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -10.3% | +15.3% | -0.2% | +25.9% | -12.5% | +15.3% |
| 5 y | 5-year | -10.3% | +111.2% | -27.5% | +100.1% | -12.5% | +97.2% |
| alltime | all time | -10.3% | >+9999.0% | -27.5% | >+9999.0% | -12.5% | >+9999.0% |
Regeneron Pharmaceuticals Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $12.23B(+8.2%) | $3.22B(-0.2%) | $12.23B(+2.6%) |
| Sep 2024 | - | $3.23B(+5.3%) | $11.93B(+2.6%) |
| Jun 2024 | - | $3.07B(+13.1%) | $11.62B(+2.8%) |
| Mar 2024 | - | $2.71B(-7.1%) | $11.31B(+0.1%) |
| Dec 2023 | $11.30B(+6.5%) | $2.92B(-0.3%) | $11.30B(+0.4%) |
| Sep 2023 | - | $2.93B(+6.3%) | $11.26B(+2.8%) |
| Jun 2023 | - | $2.75B(+1.8%) | $10.95B(+1.8%) |
| Mar 2023 | - | $2.70B(-5.9%) | $10.76B(+1.4%) |
| Dec 2022 | $10.61B(-22.2%) | $2.87B(+9.8%) | $10.61B(-9.4%) |
| Sep 2022 | - | $2.62B(+2.3%) | $11.71B(-3.2%) |
| Jun 2022 | - | $2.56B(-0.0%) | $12.09B(-13.5%) |
| Mar 2022 | - | $2.56B(-35.5%) | $13.97B(+2.5%) |
| Dec 2021 | $13.63B(+84.8%) | $3.97B(+32.3%) | $13.63B(+16.2%) |
| Sep 2021 | - | $3.00B(-32.5%) | $11.73B(+9.1%) |
| Jun 2021 | - | $4.44B(+100.2%) | $10.76B(+34.7%) |
| Mar 2021 | - | $2.22B(+7.3%) | $7.99B(+8.3%) |
| Dec 2020 | $7.38B(+27.4%) | $2.07B(+2.5%) | $7.38B(+6.2%) |
| Sep 2020 | - | $2.02B(+20.5%) | $6.95B(+7.8%) |
| Jun 2020 | - | $1.68B(+4.1%) | $6.45B(+3.9%) |
| Mar 2020 | - | $1.61B(-1.9%) | $6.20B(+7.1%) |
| Dec 2019 | $5.79B(+22.5%) | $1.64B(+8.1%) | $5.79B(+31.3%) |
| Sep 2019 | - | $1.52B(+6.0%) | $4.41B(-0.8%) |
| Jun 2019 | - | $1.43B(+19.3%) | $4.45B(-1.9%) |
| Mar 2019 | - | $1.20B(+358.0%) | $4.53B(-4.1%) |
| Dec 2018 | $4.73B(-13.6%) | $262.10M(-83.1%) | $4.73B(-20.4%) |
| Sep 2018 | - | $1.55B(+2.4%) | $5.94B(+2.7%) |
| Jun 2018 | - | $1.52B(+8.6%) | $5.79B(+2.6%) |
| Mar 2018 | - | $1.40B(-5.4%) | $5.64B(+3.0%) |
| Dec 2017 | $5.48B(+20.0%) | $1.48B(+5.7%) | $5.48B(+6.3%) |
| Sep 2017 | - | $1.40B(+2.1%) | $5.15B(+4.5%) |
| Jun 2017 | - | $1.37B(+10.7%) | $4.93B(+4.8%) |
| Mar 2017 | - | $1.23B(+7.2%) | $4.71B(+3.2%) |
| Dec 2016 | $4.56B(+22.9%) | $1.15B(-2.0%) | $4.56B(+3.8%) |
| Sep 2016 | - | $1.18B(+2.8%) | $4.40B(+3.5%) |
| Jun 2016 | - | $1.14B(+5.0%) | $4.25B(+5.8%) |
| Mar 2016 | - | $1.09B(+10.3%) | $4.01B(+8.2%) |
| Dec 2015 | $3.71B(+41.9%) | $987.25M(-4.0%) | $3.71B(+7.0%) |
| Sep 2015 | - | $1.03B(+13.0%) | $3.47B(+11.5%) |
| Jun 2015 | - | $909.78M(+15.8%) | $3.11B(+10.3%) |
| Mar 2015 | - | $785.66M(+5.8%) | $2.82B(+7.8%) |
| Dec 2014 | $2.61B(+34.1%) | $742.86M(+10.8%) | $2.61B(+7.4%) |
| Sep 2014 | - | $670.20M(+8.2%) | $2.43B(+4.8%) |
| Jun 2014 | - | $619.32M(+6.4%) | $2.32B(+9.5%) |
| Mar 2014 | - | $582.17M(+3.5%) | $2.12B(+8.8%) |
| Dec 2013 | $1.95B(+50.6%) | $562.30M(+0.7%) | $1.95B(+10.0%) |
| Sep 2013 | - | $558.45M(+33.6%) | $1.77B(+9.3%) |
| Jun 2013 | - | $418.03M(+1.8%) | $1.62B(+9.1%) |
| Mar 2013 | - | $410.61M(+6.8%) | $1.49B(+14.8%) |
| Dec 2012 | $1.29B(+193.0%) | $384.43M(-5.7%) | $1.29B(+25.7%) |
| Sep 2012 | - | $407.54M(+44.2%) | $1.03B(+42.1%) |
| Jun 2012 | - | $282.56M(+28.7%) | $724.42M(+31.9%) |
| Mar 2012 | - | $219.49M(+82.9%) | $549.28M(+24.4%) |
| Dec 2011 | $441.61M(-3.4%) | $119.99M(+17.2%) | $441.61M(-2.9%) |
| Sep 2011 | - | $102.38M(-4.7%) | $454.70M(-0.7%) |
| Jun 2011 | - | $107.42M(-3.9%) | $457.92M(-1.7%) |
| Mar 2011 | - | $111.82M(-16.0%) | $465.99M(+2.0%) |
| Dec 2010 | $456.98M | $133.08M(+26.0%) | $456.98M(+8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $105.61M(-8.6%) | $420.32M(-2.6%) |
| Jun 2010 | - | $115.48M(+12.3%) | $431.69M(+6.4%) |
| Mar 2010 | - | $102.82M(+6.6%) | $405.81M(+7.5%) |
| Dec 2009 | $377.58M(+59.0%) | $96.41M(-17.6%) | $377.58M(+12.3%) |
| Sep 2009 | - | $116.98M(+30.6%) | $336.38M(+18.2%) |
| Jun 2009 | - | $89.60M(+20.1%) | $284.68M(+11.3%) |
| Mar 2009 | - | $74.59M(+35.1%) | $255.74M(+7.7%) |
| Dec 2008 | $237.53M(+90.0%) | $55.21M(-15.4%) | $237.53M(+30.3%) |
| Sep 2008 | - | $65.29M(+7.6%) | $182.33M(+55.8%) |
| Jun 2008 | - | $60.65M(+7.6%) | $117.04M(+107.6%) |
| Mar 2008 | - | $56.38M(+468.6%) | $56.38M(+2.0%) |
| Dec 2007 | $125.02M(+126.1%) | - | - |
| Dec 2006 | $55.30M(-2.4%) | $9.92M(-21.1%) | $55.30M(-8.8%) |
| Sep 2006 | - | $12.57M(-23.6%) | $60.66M(-0.6%) |
| Jun 2006 | - | $16.45M(+0.5%) | $61.04M(+3.0%) |
| Mar 2006 | - | $16.37M(+7.1%) | $59.28M(+4.7%) |
| Dec 2005 | $56.64M(-64.3%) | $15.28M(+18.0%) | $56.64M(-33.3%) |
| Sep 2005 | - | $12.95M(-11.9%) | $84.97M(-14.6%) |
| Jun 2005 | - | $14.69M(+7.1%) | $99.56M(-11.7%) |
| Mar 2005 | - | $13.72M(-68.5%) | $112.76M(-29.0%) |
| Dec 2004 | $158.80M(+212.5%) | $43.62M(+58.4%) | $158.80M(+17.2%) |
| Sep 2004 | - | $27.53M(-1.3%) | $135.55M(+12.4%) |
| Jun 2004 | - | $27.89M(-53.3%) | $120.57M(+19.0%) |
| Mar 2004 | - | $59.77M(+193.5%) | $101.33M(+98.6%) |
| Dec 2003 | $50.82M(+227.8%) | $20.36M(+62.3%) | $51.03M(+50.7%) |
| Sep 2003 | - | $12.55M(+45.1%) | $33.85M(+29.0%) |
| Jun 2003 | - | $8.65M(-8.7%) | $26.23M(+23.2%) |
| Mar 2003 | - | $9.47M(+197.2%) | $21.29M(+37.3%) |
| Dec 2002 | $15.51M(+0.3%) | $3.19M(-35.4%) | $15.51M(-0.3%) |
| Sep 2002 | - | $4.93M(+32.9%) | $15.56M(+4.9%) |
| Jun 2002 | - | $3.71M(+0.7%) | $14.84M(-1.2%) |
| Mar 2002 | - | $3.68M(+13.7%) | $15.02M(-2.9%) |
| Dec 2001 | $15.46M(-64.6%) | $3.24M(-23.0%) | $15.46M(-31.6%) |
| Sep 2001 | - | $4.21M(+8.0%) | $22.62M(-26.8%) |
| Jun 2001 | - | $3.89M(-5.6%) | $30.91M(-23.3%) |
| Mar 2001 | - | $4.13M(-60.3%) | $40.30M(-7.6%) |
| Dec 2000 | $43.71M(+41.5%) | $10.40M(-16.7%) | $43.62M(-3.1%) |
| Sep 2000 | - | $12.49M(-6.0%) | $45.02M(+5.1%) |
| Jun 2000 | - | $13.28M(+78.4%) | $42.83M(+25.1%) |
| Mar 2000 | - | $7.45M(-36.9%) | $34.25M(+10.8%) |
| Dec 1999 | $30.90M(-7.2%) | $11.80M(+14.6%) | $30.90M(+23.1%) |
| Sep 1999 | - | $10.30M(+119.1%) | $25.10M(+3.3%) |
| Jun 1999 | - | $4.70M(+14.6%) | $24.30M(-23.8%) |
| Mar 1999 | - | $4.10M(-31.7%) | $31.90M(-4.5%) |
| Dec 1998 | $33.30M(+37.0%) | $6.00M(-36.8%) | $33.40M(+5.4%) |
| Sep 1998 | - | $9.50M(-22.8%) | $31.70M(+4.6%) |
| Jun 1998 | - | $12.30M(+119.6%) | $30.30M(+25.7%) |
| Mar 1998 | - | $5.60M(+30.2%) | $24.10M(-0.4%) |
| Dec 1997 | $24.30M(+5.7%) | $4.30M(-46.9%) | $24.20M(+21.6%) |
| Sep 1997 | - | $8.10M(+32.8%) | $19.90M(+68.6%) |
| Jun 1997 | - | $6.10M(+7.0%) | $11.80M(+107.0%) |
| Mar 1997 | - | $5.70M(-181.4%) | $5.70M(-181.4%) |
| Dec 1996 | $23.00M(-518.2%) | - | - |
| Sep 1993 | - | -$7.00M(+133.3%) | -$7.00M(+48.9%) |
| Dec 1991 | -$5.50M(+323.1%) | -$3.00M(+500.0%) | -$4.70M(+176.5%) |
| Sep 1991 | - | -$500.00K(-58.3%) | -$1.70M(+41.7%) |
| Jun 1991 | - | -$1.20M | -$1.20M |
| Dec 1990 | -$1.30M | - | - |
FAQ
- What is Regeneron Pharmaceuticals annual gross profit?
- What is the all time high annual gross profit for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual gross profit year-on-year change?
- What is Regeneron Pharmaceuticals quarterly gross profit?
- What is the all time high quarterly gross profit for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly gross profit year-on-year change?
- What is Regeneron Pharmaceuticals TTM gross profit?
- What is the all time high TTM gross profit for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals TTM gross profit year-on-year change?
What is Regeneron Pharmaceuticals annual gross profit?
The current annual gross profit of REGN is $12.23B
What is the all time high annual gross profit for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual gross profit is $13.63B
What is Regeneron Pharmaceuticals annual gross profit year-on-year change?
Over the past year, REGN annual gross profit has changed by +$930.10M (+8.23%)
What is Regeneron Pharmaceuticals quarterly gross profit?
The current quarterly gross profit of REGN is $3.22B
What is the all time high quarterly gross profit for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly gross profit is $4.44B
What is Regeneron Pharmaceuticals quarterly gross profit year-on-year change?
Over the past year, REGN quarterly gross profit has changed by +$306.50M (+10.51%)
What is Regeneron Pharmaceuticals TTM gross profit?
The current TTM gross profit of REGN is $12.23B
What is the all time high TTM gross profit for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high TTM gross profit is $13.97B
What is Regeneron Pharmaceuticals TTM gross profit year-on-year change?
Over the past year, REGN TTM gross profit has changed by +$930.10M (+8.23%)